Johnson, Steven M <br/><br/>
Toward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.  [electronic resource] 

 -  Journal of medicinal chemistry  Feb 2009 
 - 1115-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1520-4804 
<br/><br/><label>Standard No.: </label>10.1021/jm801347s  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amyloid--antagonists & inhibitors<br/>Amyloidosis--prevention & control<br/>Benzamides--chemistry<br/>Crystallography, X-Ray<br/>Cyclooxygenase 1--drug effects<br/>Drug Design<br/>Humans<br/>Molecular Structure<br/>Prealbumin--antagonists & inhibitors<br/>Receptors, Thyroid Hormone--metabolism<br/>Structure-Activity Relationship